Category: Allies & Partnerships


Advancing Melanoma Research in Times of Uncertainty

By Cody R. Barnett, MRA Director of Communications | 9 June 2021 In Allies & Partnerships, Melanoma Stories, Policy, Prevention, Science, Treatment

Each year, the annual MRA Scientific Retreat brings hundreds of people from across the melanoma research ecosystem together to exchange ideas, report on scientific progress, celebrate achievements, and mourn the losses. In these ways, the 2021 Retreat was no different.

Read More


SPOTMYUV: Your Sunscreen’s New Best Friend

By Cody R. Barnett, MRA Director of Communications | 20 May 2021 In Allies & Partnerships, Prevention

SPOTMYUV, a small, water-resistant sticker applied to any skin exposed to direct sunlight such as your arm or shoulder, helps the wearer know when it is time to reapply their sunscreen by changing color. Throughout the day, a SPOT sticker works to absorb the sunscreen’s UV protecting ingredients at about the same rate as your skin. The SPOT is clear when you are protected by your sunscreen and quickly turns into a deep purple as the sunscreen loses its effectiveness. By monitoring the SPOT, you get a real-time way to monitor your sunscreen without chancing sunburn.

Read More


A New Treatment Approach in the Arsenal: Neoadjuvent Therapy

23 April 2021 In Allies & Partnerships, News, Science, Treatment

Surgery is the backbone of melanoma treatment and is curative for the vast majority of patients with localized melanoma. However, even if surgery successfully removes all detectible traces of tumor tissue, some patients will still experience a melanoma relapse. Can neoadjuvant therapy, an experimental approach, reduce the risk of recurrence?

Read More


Against the Odds: Racing for Melanoma Research

19 April 2021 In Allies & Partnerships, Melanoma Stories, Treatment

Patrick O’Neill along with his four closest college friends and fellow Boat Racing, LLC members, find themselves in a very implausible position: first-time horse owners heading to the Kentucky Derby—horseracing’s pinnacle event.

Read More


Summer Kramer: Aligning Passion with Purpose

By Michael Kaplan, MRA President & CEO | 19 April 2021 In Allies & Partnerships, Melanoma Stories, Prevention

Frustrated with her inability to find stylish UPF protective clothing after her own melanoma diagnosis, Summer Kramer founded her own company called SUMMERSKIN. Now, eight years later, she has aligned her passion with purpose through a new partnership with the Melanoma Research Alliance.

Read More


Five Melanoma Research Highlights to Look Forward to in 2021

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 13 January 2021 In Allies & Partnerships, News, Prevention, Science, Treatment

At MRA, every day we are focused on how melanoma research can be reimagined to accelerate progress similar to what has been accomplished in record time with COVID-19 research, and look forward to a future not only void of COVID-19; but where suffering and death due to melanoma are no more.

Read More


Creating Art to Create Change: The Power to Heal & Mobilize Community

By Renee Orcione, MRA Development Associate | 11 January 2021 In Allies & Partnerships, Melanoma Stories

Following the initial shock of her diagnosis and the strain of facing treatments on her own, Barbara was faced with yet another hurdle. Her arm surgery had left it nearly immobile. Not only was this a problem for her daily functioning, it made it extremely difficult for Barbara to pursue her lifelong passion of art.

Read More


Fueling a Revolution: Driving Research Forward

21 October 2020 In Allies & Partnerships, Melanoma Stories, News, Policy, Prevention, Science, Treatment

MRA is powering a revolution in melanoma research. A revolution that is not only benefiting patients with melanoma but also impacting the field of oncology at large.

Read More


Painting a Portrait of the Melanoma Clinical Trial Participant

By Cody R. Barnett, MRA Director of Communications | 26 June 2020 In Allies & Partnerships

MRA Chief Science Officer Marc Hurlbert, MRA Director of Communications Cody Barnett, and Antidote's Head of Partnerships Lindsey Wahlstrom-Edwards discuss what matters most to melanoma patients when it comes to participating in clinical trials.

Read More


Maintaining Momentum in Melanoma Research

8 June 2020 In Allies & Partnerships, News, Policy, Prevention, Science, Treatment

The last decade has been one of substantial progress and hope for many melanoma patients, researchers, and clinicians. With 12 new therapeutic approaches now approved to treat melanoma, many advanced-stage patients are seeing their tumors shrink or disappear, and are experiencing renewed hope for a brighter future.

Read More


Login

×